𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

✍ Scribed by Francisco C. Muñoz-Casares; Sebastián Rufián; María J. Rubio; Carlos J. Díaz; Rafael Díaz; Ángela Casado; Álvaro Arjona; María C. Muñoz-Villanueva; Jordi Muntané

Book ID
107597577
Publisher
Springer Milan
Year
2009
Tongue
Spanish
Weight
410 KB
Volume
11
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and potential benefit of hyperthe
Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer
✍ Franco Roviello; Enrico Pinto; Giovanni Corso; Corrado Pedrazzani; Stefano Carus 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## Objectives To analyze the outcomes of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. ## Methods Fifty‐three patients with peritoneal carcinomatosis from primary (45 cases) and recurrent (8 cases) ovarian cancer were previously treat

Cytoreductive surgery (peritonectomy pro
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer
✍ Angelo Di Giorgio; Enzo Naticchioni; Daniele Biacchi; Simone Sibio; Fabio Accarp 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. ## METHODS. In an open, p